NUCB2 and urinary bladder cancer: “Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer,” Disease Markers, no. 2018 (2018): 1–9.